Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-09-08Clinical Trial Update: T-Reg Cell Kinetics, Stem Cell Transplant, REGALE [NA]
A terminated clinical trial (NCT00578539) from Baylor College of Medicine studied regulatory T cell kinetics in stem cell transplantation, w…
-
CLINICAL_TRIALS trial_result · 2014-09-05Clinical Trial Update: Rituximab After Autologous Stem Cell Transplant for Relapsed B-cell Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial results evaluating rituximab after autologous stem cell transplant in relapsed B-cell non-Hodgkin lymphoma have been completed…
-
CLINICAL_TRIALS trial_result · 2014-09-01Clinical Trial Update: Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating agatolimod sodium in combination with rituximab and Yttrium-90 ibritumomab tiuxetan for adults with re…
-
CLINICAL_TRIALS trial_result · 2014-08-27Clinical Trial Update: Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia [Phase 1]
Phase 1 trial of vorinostat combined with decitabine in adults with advanced solid tumors or relapsed/refractory hematologic cancers, includ…
-
CLINICAL_TRIALS trial_result · 2014-08-25Clinical Trial Update: Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat T Cell or Natural Killer (NK) Cell Lymphoma [Phase 2]
This Phase 2 trial update describes BuEAM conditioning with busulfan, etoposide, cytarabine, and melphalan before autologous stem cell trans…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2014-08-25Clinical Trial Update: Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat B Cell Lymphoma Except for Diffuse Large B Cell Lymphoma [Phase 2]
Phase 2 trial evaluating BuEAM conditioning (Busulfan, Etoposide, Cytarabine, Melphalan) before autologous stem cell transplantation for non…
-
CLINICAL_TRIALS trial_result · 2014-08-21Clinical Trial Update: A Study of Induction and Maintenance Treatment With MabThera (Rituximab) in Patients With Indolent B-Cell Nonfollicular Lymphomas [Phase 2]
Phase 2 study evaluating induction and maintenance Rituximab (MabThera) in patients with indolent B-cell non-Hodgkin lymphoma; trial complet…
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: Oncaspar/Doxil/Decadron in Patients With Refractory Lymphoid Malignancies [Phase 2]
Phase 2 trial evaluating Oncaspar (pegaspargase), Doxil (liposomal doxorubicin), and Decadron (dexamethasone) in refractory lymphoid maligna…
-
CLINICAL_TRIALS withdrawal · 2014-08-13Clinical Trial Update: A Pharmacokinetic Study to Access How the Body Absorbs and Removes ABT-199 in Adults With Non-Hodgkin's Lymphoma [Phase 1]
A Phase 1 pharmacokinetic study of ABT-199 (venetoclax) in adults with non-Hodgkin's lymphoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-08-01Clinical Trial Update: Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 study evaluating combination chemotherapy followed by peripheral stem cell transplantation in children with recurrent or refractory …
-
CLINICAL_TRIALS trial_result · 2014-08-01Clinical Trial Update: CPG 7909 + Local Radiotherapy in Recurrent Low-Grade Lymphomas [Phase 1, Phase 2]
A Phase 1/2 study evaluating CPG 7909 with local radiotherapy for recurrent low-grade lymphomas has completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-07-31Clinical Trial Update: EMD 521873 in Advanced Solid Tumors, MTD Finding [Phase 1]
Phase 1 study evaluating the maximum tolerated dose and safety of EMD 521873 in patients with Non-Hodgkin lymphoma; the trial is completed.
-
CLINICAL_TRIALS trial_result · 2014-07-29Clinical Trial Update: Evaluation of the Analgesy With Emla and/or Nitrous Oxide in Pediatric Patients for Lumbar Puncture [Phase 4]
This document reports the completion of a Phase 4 trial evaluating EMLA cream and/or nitrous oxide for analgesia in pediatric patients durin…
-
CLINICAL_TRIALS trial_result · 2014-07-25Clinical Trial Update: Combination Chemotherapy in Treating Children With Stage III or Stage IV Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia [Phase 1]
This update describes a Phase 1 trial of a combination chemotherapy regimen in children with advanced Non-Hodgkin lymphoma or acute lymphobl…
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma [Phase 3]
A Phase 3 trial by the Children's Oncology Group evaluated less-intensive therapy for children with Non-Hodgkin lymphoma; the study status i…
-
CLINICAL_TRIALS research · 2014-07-24Clinical Trial Update: S8516-S8736-S9125-S9240 Research Study of Genes in Tissue Samples From Patients With B-cell Non-Hodgkin Lymphoma
This clinical trial update reports a completed study examining gene analyses in tissue samples from patients with B-cell non-Hodgkin lymphom…
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma [Phase 3]
A Phase 3 trial evaluating combination chemotherapy for pediatric patients with advanced-stage large cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-04Clinical Trial Update: Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD [Phase 2]
Phase 2 trial update evaluating low-dose interleukin-2 in patients undergoing allogeneic hematopoietic stem cell transplantation to address …
-
CLINICAL_TRIALS trial_result · 2014-07-01Clinical Trial Update: A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease [Phase 1]
This document reports the completion of a Phase 1 safety and efficacy study of CNTO-328 (siltuximab) in patients with B-cell non-Hodgkin lym…
-
CLINICAL_TRIALS trial_result · 2014-07-01Clinical Trial Update: Non-Hodgkin Lymphoma in Elderly Patients Above the Age of 80 in the Rituximab Era
Completed a clinical trial evaluating Non-Hodgkin lymphoma in patients over 80 years old in the Rituximab era. The update summarizes the stu…
-
CLINICAL_TRIALS trial_result · 2014-06-10Clinical Trial Update: Cyclophosphamide as Sole Graft-Versus-Host-Prophylaxis After Allogeneic Stem Cell Transplantation [Phase 2]
Phase 2 study evaluating cyclophosphamide as the sole graft-versus-host disease prophylaxis after allogeneic stem cell transplantation has c…
-
CLINICAL_TRIALS trial_result · 2014-06-02Clinical Trial Update: Efficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell Transplant [Phase 2]
Phase 2 trial evaluating the efficacy of T cell-depleted allogeneic non-myeloablative stem cell transplantation; the study in Hodgkin lympho…
-
CLINICAL_TRIALS trial_result · 2014-05-29Clinical Trial Update: Pegfilgrastim vs. Filgrastim - Comparison of Mobilized Blood Stem Cells in Patients With Non Hodgkin-lymphoma [Phase 2]
Phase 2 trial comparing pegfilgrastim with filgrastim for mobilized blood stem cell collection in patients with non-Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2014-05-29Clinical Trial Update: Radioimmunotherapy With 90Y-ibritumomab Tiuxetan as Part of a Dose Reduced Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation for the Treatment of Non-Hodgkin Lymphoma [Phase 1, Phase 2]
This clinical trial reports results for using 90Y-ibritumomab tiuxetan as part of a reduced-intensity conditioning regimen before allogeneic…
-
CLINICAL_TRIALS trial_result · 2014-05-26Clinical Trial Update: A Brentuximab Vedotin Trial for Patients Who Have Previously Participated in a Brentuximab Vedotin Study [Phase 2]
Phase 2 trial update of brentuximab vedotin in patients who previously participated in a brentuximab vedotin study, with results posted.